These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Use of a temporary intraoperative mesentericoportal shunt for pancreatic resection for locally advanced pancreatic cancer with portal vein occlusion and portal hypertension. Bachellier P, Rosso E, Fuchshuber P, Addeo P, David P, Oussoultzoglou E, Lucescu I. Surgery; 2014 Mar; 155(3):449-56. PubMed ID: 24462078 [Abstract] [Full Text] [Related]
25. Central pancreatectomy: single-center experience of 50 cases. Adham M, Giunippero A, Hervieu V, Courbière M, Partensky C. Arch Surg; 2008 Feb; 143(2):175-80; discussion 180-1. PubMed ID: 18283143 [Abstract] [Full Text] [Related]
26. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. Cleary SP, Gryfe R, Guindi M, Greig P, Smith L, Mackenzie R, Strasberg S, Hanna S, Taylor B, Langer B, Gallinger S. J Am Coll Surg; 2004 May; 198(5):722-31. PubMed ID: 15110805 [Abstract] [Full Text] [Related]
27. Safety of portal vein resection using centrifugal pump-assisted venous bypass between the superior mesenteric vein and the umbilical vein. Suzuki Y, Yoshida I, Ku Y, Fujino Y, Tanioka Y, Fukumoto T, Iwasaki T, Tominaga M, Kuroda Y. Hepatogastroenterology; 2004 May; 51(58):1183-6. PubMed ID: 15239274 [Abstract] [Full Text] [Related]
28. Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma. O'Connor JK, Sause WT, Hazard LJ, Belnap LP, Noyes RD. Int J Radiat Oncol Biol Phys; 2005 Nov 15; 63(4):1060-6. PubMed ID: 15978737 [Abstract] [Full Text] [Related]
29. Factors influencing outcome in patients undergoing portal vein resection for adenocarcinoma of the pancreas. Banz VM, Croagh D, Coldham C, Tanière P, Buckels J, Isaac J, Mayer D, Muiesan P, Bramhall S, Mirza DF. Eur J Surg Oncol; 2012 Jan 15; 38(1):72-9. PubMed ID: 22054617 [Abstract] [Full Text] [Related]
34. Critical appraisal of 232 consecutive distal pancreatectomies with emphasis on risk factors, outcome, and management of the postoperative pancreatic fistula: a 21-year experience at a single institution. Goh BK, Tan YM, Chung YF, Cheow PC, Ong HS, Chan WH, Chow PK, Soo KC, Wong WK, Ooi LL. Arch Surg; 2008 Oct 15; 143(10):956-65. PubMed ID: 18936374 [Abstract] [Full Text] [Related]
35. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Schnelldorfer T, Ware AL, Sarr MG, Smyrk TC, Zhang L, Qin R, Gullerud RE, Donohue JH, Nagorney DM, Farnell MB. Ann Surg; 2008 Mar 15; 247(3):456-62. PubMed ID: 18376190 [Abstract] [Full Text] [Related]
38. Mono-bloc total spleno-pancreaticoduodenectomy for pancreatic head carcinoma with portal-mesenteric venous invasion. A prospective randomized study. Lygidakis NJ, Singh G, Bardaxoglou E, Dedemadi G, Sgourakis G, Nestoridis J, Malliotakis A, Pedonomou M, Solomou EK, Safioleas M, Alamani M, Grigorakos L, Merikas EM. Hepatogastroenterology; 2004 Mar 15; 51(56):427-33. PubMed ID: 15086174 [Abstract] [Full Text] [Related]